|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bauer KR, Brown M, Cress RD, Parise CA and
Caggiano V: Descriptive analysis of estrogen receptor
(ER)-negative, progesterone receptor (PR)-negative, and
HER2-negative invasive breast cancer, the so-called triple-negative
phenotype: A population-based study from the California Cancer
Registry. Cancer. 109:1721–1728. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Elias AD: Triple-negative breast cancer: A
short review. Am J Clin Oncol. 33:637–645. 2010. View Article : Google Scholar
|
|
5
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rakha EA, Elsheikh SE, Aleskandarany MA,
Habashi HO, Green AR, Powe DG, El-Sayed ME, Benhasouna A, Brunet
JS, Akslen LA, et al: Triple-negative breast cancer: Distinguishing
between basal and nonbasal subtypes. Clin Cancer Res. 15:2302–2310.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng J, Kang X, Zhang S and Yeh ET:
SUMO-specific protease 1 is essential for stabilization of
HIF1alpha during hypoxia. Cell. 131:584–595. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li R, Wei J, Jiang C, Liu D, Deng L, Zhang
K and Wang P: Akt SUMOylation regulates cell proliferation and
tumorigenesis. Cancer Res. 73:5742–5753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li T, Huang S, Dong M, Gui Y and Wu D:
Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate
cancer patients undergoing radical prostatectomy. Urol Oncol.
31:1539–1545. 2013. View Article : Google Scholar
|
|
10
|
Wang RT, Zhi XY, Zhang Y and Zhang J:
Inhibition of SENP1 induces radiosensitization in lung cancer
cells. Exp Ther Med. 6:1054–1058. 2013.PubMed/NCBI
|
|
11
|
Xu Y, Li J, Zuo Y, Deng J, Wang LS and
Chen GQ: SUMO-specific protease 1 regulates the in vitro and in
vivo growth of colon cancer cells with the upregulated expression
of CDK inhibitors. Cancer Lett. 309:78–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Burdelski C, Menan D, Tsourlakis MC, Kluth
M, Hube-Magg C, Melling N, Minner S, Koop C, Graefen M, Heinzer H,
et al: The prognostic value of SUMO1/Sentrin specific peptidase 1
(SENP1) in prostate cancer is limited to ERG-fusion positive tumors
lacking PTEN deletion. BMC Cancer. 15:5382015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Q, Xia N, Li T, Xu Y, Zou Y, Zuo Y,
Fan Q, Bawa-Khalfe T, Yeh ET and Cheng J: SUMO-specific protease 1
promotes prostate cancer progression and metastasis. Oncogene.
32:2493–2498. 2013. View Article : Google Scholar
|
|
14
|
Wang C, Tao W, Ni S, Chen Q, Zhao Z, Ma L,
Fu Y and Jiao Z: Tumor-suppressive microRNA-145 induces growth
arrest by targeting SENP1 in human prostate cancer cells. Cancer
Sci. 106:375–382. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang H, Tang Y, Guo W, Du Y, Wang Y, Li P,
Zang W, Yin X, Wang H, Chu H, et al: Up-regulation of microRNA-138
induce radiosensitization in lung cancer cells. Tumour Biol.
35:6557–6565. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma C, Wu B, Huang X, et al: SUMO-specific
protease 1 regulates pancreatic cancer cell proliferation and
invasion by targeting MMP-9. Tumour Biol. 35:12729–12735. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang BB, Gao QM, Liang W, Xiu B, Zhang WJ
and Liang AB: Down-regulation of SENP1 expression increases
apoptosis of Burkitt lymphoma cells. Asian Pac J Cancer Prev.
13:2045–2049. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei M, Liu B, Gu Q, Su L, Yu Y and Zhu Z:
Stat6 cooperates with Sp1 in controlling breast cancer cell
proliferation by modulating the expression of p21(Cip1/WAF1) and
p27 (Kip1). Cell Oncol (Dordr). 36:79–93. 2013. View Article : Google Scholar
|
|
19
|
Bawa-Khalfe T, Cheng J, Lin SH, Ittmann MM
and Yeh ET: SENP1 induces prostatic intraepithelial neoplasia
through multiple mechanisms. J Biol Chem. 285:25859–25866. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaikkonen S, Jääskeläinen T, Karvonen U,
Rytinki MM, Makkonen H, Gioeli D, Paschal BM and JJ: SUMO-specific
protease 1 (SENP1) reverses the hormone-augmented SUMOylation of
androgen receptor and modulates gene responses in prostate cancer
cells. Mol Endocrinol. 23:292–307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tan M, Gong H, Wang J, Tao L, Xu D, Bao E,
Liu Z and Qiu J: SENP2 regulates MMP13 expression in a bladder
cancer cell line through SUMOylation of TBL1/TBLR1. Sci Rep.
5:139962015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jacques C, Baris O, Prunier-Mirebeau D,
Savagner F, Rodien P, Rohmer V, Franc B, Guyetant S, Malthiery Y
and Reynier P: Two-step differential expression analysis reveals a
new set of genes involved in thyroid oncocytic tumors. J Clin
Endocrinol Metab. 90:2314–2320. 2005. View Article : Google Scholar
|
|
23
|
Kim EY, Chen L, Ma Y, Yu W, Chang J,
Moskowitz IP and Wang J: Enhanced desumoylation in murine hearts by
overexpressed SENP2 leads to congenital heart defects and cardiac
dysfunction. J Mol Cell Cardiol. 52:638–649. 2012. View Article : Google Scholar :
|
|
24
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shackelford RE, Kaufmann WK and Paules RS:
Cell cycle control, checkpoint mechanisms, and genotoxic stress.
Environ Health Perspect. 107(Suppl 1): 5–24. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Groshong SD, Owen GI, Grimison B, Schauer
IE, Todd MC, Langan TA, Sclafani RA, Lange CA and Horwitz KB:
Biphasic regulation of breast cancer cell growth by progesterone:
Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).
Mol Endocrinol. 11:1593–1607. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Gao P, Long M, Lin F, Wei JX, Ren
JH, Yan L, He T, Han Y and Zhang HZ: Essential role of cell cycle
regulatory genes p21 and p27 expression in inhibition of breast
cancer cells by arsenic trioxide. Med Oncol. 28:1225–1254. 2011.
View Article : Google Scholar
|
|
28
|
Akter H, Park M, Kwon OS, Song EJ, Park WS
and Kang MJ: Activation of matrix metalloproteinase-9 (MMP-9) by
neurotensin promotes cell invasion and migration through ERK
pathway in gastric cancer. Tumour Biol. 36:6053–6062. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi M, Cao M, Song J, Liu Q, Li H, Meng F,
Pan Z, Bai J and Zheng J: PinX1 inhibits the invasion and
metastasis of human breast cancer via suppressing NF-κB/MMP-9
signaling pathway. Mol Cancer. 14:662015. View Article : Google Scholar
|
|
31
|
Sun YS, Zhao Z and Zhu HP: Hispolon
inhibits TPA-induced invasion by reducing MMP-9 expression through
the NF-κB signaling pathway in MDA-MB-231 human breast cancer
cells. Oncol Lett. 10:536–542. 2015.PubMed/NCBI
|
